Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Chaihushugan granules (also known as modified Chaihu Shugan San granules) is a traditional Chinese medicine (TCM) herbal formulation developed by Jiangsu Province Hospital on Integration of Chinese and Western Medicine. It is a modified version of the classic Chaihu Shugan San (Bupleurum Liver-Coursing Powder) formula, prepared in a granule dosage form. The formulation is designed to soothe the liver, regulate qi, and harmonize the stomach. It is being evaluated in clinical trials for the treatment of chronic atrophic gastritis (CAG), particularly in patients presenting with liver-stomach disharmony or liver qi stagnation syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Chaihushugan granules.